EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial

Gunnar Helge Sjøen iD, Tor Hugo Hauge, Ragnhild Sørum Falk iD, Tor Inge Tønnessen iD, Eldrid Langesæter

Acta Anaesthesiologica Scandinavica · 2026

DOI: 10.1111/aas.70138 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2026. Verfasst von Gunnar Helge Sjøen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Fonna Hospital Trust, Haugesund, Norway. Hauptthemen laut MEDLINE: Ephedrine, Norepinephrine, Phenylephrine, Vasoconstrictor Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Western Norway Regional Health Authority, Helse Vest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ephedrine, phenylephrine, and norepinephrine are commonly used to manage hypotension during the induction of anaesthesia. The objective of this study was to evaluate whether prophylactic administration of assumed equipotent doses of these vasopressors could maintain systolic arterial blood pressure (SAP) and heart rate (HR) within 80% of baseline for the first 5 min following induction of anaesthesia.

Methods

This randomised, double‐blind, dose‐controlled study was conducted at the Day Surgery Unit of Haugesund Hospital, Norway. One hundred and twenty‐eight healthy women scheduled for gynaecological surgery were randomly allocated in a 1:1:1:1 ratio to receive prophylactic administration of ephedrine (0.1 mg/kg), phenylephrine (1 μg/kg), norepinephrine (0.1 mg/kg), or placebo (sodium chloride 9 mg/mL) at a volume of 0.1 mL/kg. Anaesthesia was induced using target‐controlled infusion (TCI) of propofol and remifentanil. The initial 2.5 min constituted a sedation phase, after which the targets of propofol and remifentanil were increased, and the assigned vasopressor was administered. Beat‐to‐beat haemodynamic monitoring was performed using the LiDCOplus system. The primary outcome variables were the maximal decrease in SAP and HR within 5 min following bolus administration. Secondary outcome measures included changes in stroke volume (SV), cardiac output (CO), and systemic vascular resistance (SVR).

Results

The absolute changes in SAP (mean ± standard deviation) following vasopressor administration were −27 ± 8.9 (ephedrine), −40 ± 11 (phenylephrine), −41 ± 13 (norepinephrine), and −42 ± 10 (placebo) mmHg. The differences (95% confidence interval [CI]) in the maximal SAP change between placebo and the vasopressors were as follows: ephedrine, −15 (−22, −9.9) mmHg; phenylephrine, −2.3 (−8.8, 4.2) mmHg; and norepinephrine, −1.7 (−8.3, 4.9) mmHg. Relative reductions in SAP from baseline to minimum values were −20% for ephedrine, −30% for phenylephrine, −30% for norepinephrine, and −32% for placebo. The absolute changes (median, interquartile range) in HR with ephedrine, phenylephrine, norepinephrine, and placebo were −10 (−6.2 to −18), −19 (−17 to −26), −23 (−20 to −33), and −15 (−9.5 to −21) bpm, respectively. Relative changes from baseline to minimum values in HR were −17% for ephedrine, −30% for phenylephrine, −37% for norepinephrine, and −22% for placebo. The differences in SV change between groups were small. CO was best preserved with ephedrine (−22% ± 11%), while phenylephrine and norepinephrine were associated with greater reductions (−38% ± 7.8% and −42% ± 9.8%, respectively). SVR increased most markedly in the norepinephrine group, followed by phenylephrine, with the smallest increase observed in the ephedrine group.

Conclusion

Prophylactic administration of ephedrine effectively maintained SAP, HR, and CO within the first 5 min following bolus injection at induction with propofol and remifentanil. In contrast, bolus administration of norepinephrine and phenylephrine demonstrated a short duration of action, with SAP comparable to placebo at 5 min. Based on these findings, prophylactic administration of a bolus ephedrine is recommended, whereas prophylactic phenylephrine or norepinephrine injections may not be clinically preferable for bolus use in this context. Trial Registration ClinicalTrials.gov identifier NCT 03864094, March 6, 2019 This trial assessed circulatory responses to three different commonly used vasoactive support (vasopressor) drugs given as a single bolus together anesthetic induction propofol and remifentanil, and this in a cardiovascularly healthy adult surgical cohort. Results demonstrated that pharmacodynamic patterns with the three different test drugs, along with a no‐prophylactic vasopressor comparitor. Findings showed a favorable profile for ephedrine compared to phenylephrine or noradrenaline if choosing to give a vasopressor in this way.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EphedrineNorepinephrinePhenylephrineVasoconstrictor AgentsAnesthesia, GeneralHemodynamicsHumansFemaleDouble-Blind MethodAdultHeart RateMiddle AgedBlood PressureYoung AdultHypotension

Stichwörter der Autor:innen

ephedrinehaemodynamicsnorepinephrinephenylephrinephysiological effects of drugspropofolremifentanil

Substanzen

EphedrineNorepinephrinePhenylephrineVasoconstrictor Agents

Autor:innen und Institutionen

  • Department of Anaesthesiology, Fonna Hospital Trust, Haugesund, Norway.
  • Department of Research and Innovation, Fonna Hospital Trust, Haugesund, Norway.
  • Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Norwegian Ministry of Trade, Industry and Fisheries, Oslo, Norway.
  • Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

ORCID-Profile: Gunnar Helge Sjøen, Ragnhild Sørum Falk, Tor Inge Tønnessen

Förderung

  • Western Norway Regional Health Authority
  • Helse Vest

Zitieren

APA

Sjøen, G. H., Hauge, T. H., Falk, R. S., Tønnessen, T. I., & Langesæter, E. (2026). Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70138

Vancouver

Sjøen GH, Hauge TH, Falk RS, Tønnessen TI, Langesæter E. Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial. Acta Anaesthesiologica Scandinavica. 2026. doi:10.1111/aas.70138

BibTeX
@article{Sjen2026,
  author = {Sjøen, Gunnar Helge and Hauge, Tor Hugo and Falk, Ragnhild Sørum and Tønnessen, Tor Inge and Langesæter, Eldrid},
  title = {Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2026},
  doi = {10.1111/aas.70138}
}
Kostenlos starten →